Carvedilol Prospective Randomized Cumulative Survival

Trial Profile

Carvedilol Prospective Randomized Cumulative Survival

Discontinued
Phase of Trial: Phase III

Latest Information Update: 02 Oct 2006

At a glance

  • Drugs Carvedilol (Primary) ; Spironolactone
  • Indications Chronic heart failure; Heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms COPERNICUS
  • Sponsors GlaxoSmithKline; Roche
  • Most Recent Events

    • 02 Oct 2006 Status change
    • 30 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top